北京大学学报(医学版) ›› 2016, Vol. 48 ›› Issue (6): 1032-1037. doi: 10.3969/j.issn.1671-167X.2016.06.019

• 论著 • 上一篇    下一篇

上尿路尿路上皮癌术前预后相关因素分析及初步风险分层模型构建

邢云超,熊耕砚,方东,张争,蔡林,张雷,何志嵩,李学松△,周利群△   

  1. (北京大学第一医院泌尿外科,北京大学泌尿外科研究所,国家泌尿、男性生殖系肿瘤研究中心,北京100034)
  • 出版日期:2016-12-18 发布日期:2016-12-18
  • 通讯作者: 李学松,周利群 E-mail: pineneedle@sina.com, zhoulqmail@sina.com
  • 基金资助:

    国家自然科学基金(81372746)、北京市自然科学基金(7152416)、首都临床特色应用研究与临床推广基金(Z151100004015173)和北京大学医学部与台湾大学医学合作研究项目基金(BMU20120318)资助

Preoperative prognostic factors and preoperative risk stratification of upper tract urothelial carcinoma

XING Yun-chao, XIONG Geng-yan, FANG Dong, ZHANG Zheng, CAI Lin, ZHANG Lei, HE Zhi-song, LI Xue-song△, ZHOU Li-qun△   

  1. (Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center, Beijing 100034, China)
  • Online:2016-12-18 Published:2016-12-18
  • Contact: LI Xue-song, ZHOU Li-qun E-mail: pineneedle@sina.com, zhoulqmail@sina.com
  • Supported by:

    Supported by the National Natural Science Foundation of China (81372746), the Beijing Natural Science Foundation (7152416), the Capital Foundation for Clinical Characteristics and Application Research (Z151100004015173), and the Medical Cooperative Research Project Fund of Peking University Health Science Center and Taiwan University (BMU20120318)

摘要:

目的:分析上尿路尿路上皮癌(upper tract urothelial carcinoma,UTUC)患者的术前预后因子,并构建适合中国患者的术前风险评估模型。方法:收集北京大学第一医院2003年至2013年的686例UTUC患者的临床和随访资料进行回顾性分析。结果:686例患者中,男性303例(44.2%),女性383例(55.8%),术后高分期(T3和T4)肿瘤203例(29.6%),高分级(G3)肿瘤300例(43.7%),淋巴结转移(N1)54例(7.9%),其中,肾盂肿瘤、肿瘤长径大于5 cm、肾小球滤过率(estimated glomerular filtration rate, eGFR)≥30 mL/min和男性与术后肿瘤高分期相关;输尿管肿瘤、肿瘤长径大于5 cm、没有吸烟史与术后肿瘤高分级相关;肾盂肿瘤、肿瘤长径大于5 cm和术前贫血与术后淋巴结转移相关。患者的平均随访时间65个月,其间有208例(30.3%)患者死于肿瘤,210例(30.6%)患者出现了膀胱复发,其中肿瘤长径大于5 cm(P=0.001)、伴随同侧肾积水(P=0.041)和术前贫血(P=0.001)是患者术后肿瘤特异性死亡的独立危险因子,输尿管肿瘤(P=0.04)、多发肿瘤(P=0.005)和术前血肌酐含量大于133 μmol/L(P=0.036)是患者术后膀胱复发的独立危险因素。结论:在UTUC患者常见的术前临床参数中,肿瘤长径大于5 cm、伴随同侧肾积水和术前贫血与术后肿瘤特异性生存呈独立相关,输尿管肿瘤、多发肿瘤和术前血肌酐大于133 μmol/L与术后膀胱复发呈独立相关。基于这些术前预后因素构建的中国患者术前风险分层系统,可以帮助临床医生在术前就对患者进行初步的风险评估,并指导后续的临床治疗。

关键词: 尿道上皮, 癌, 移行细胞, 肿瘤复发, 局部, 预后, 危险因素

Abstract:

Objective: To identify the preoperative prognostic factors of upper tract urothelial carcinoma (UTUC) and construct preoperative risk stratification system. Methods: A retrospective study including 686 patients who were diagnosed with UTUC and received radical nephroureterectomy or partial ureterectomy in Peking University First Hospital during 2003 and 2013. Results: Of the 686 UTUC patients, 303 (44.2%) were male and 383 (55.8%) female. The postoperative pathological examination showed that 203 (29.6%) had high tumor stages (T3, T4), 300 (43.7%) had high tumor grades (G3) and 54 (7.9%) had lymph nodes metastasis (N1). After multivariate analysis, renal pelvic tumor, large tumor, estimated glomerular filtration rate (eGFR) ≥30 mL/min, and male were associated with high tumor stage. Ureteral tumor, large tumor, and non-smoking history were associated with high tumor grade. Renal pelvis tumor, large tumor, and preoperative anemia were associated with positive N status. During the follow-up, 208 (30.3%) died for cancer and 210 (30.6%) developed intravesical recurrence. Multivariate analysis showed: large tumor (P=0.001), concomitant ipsilateral hydronephrosis (P=0.041), and preoperative anemia (P=0.001) were independently associated cancer-specific mortality after surgery, while ureteral tumor (P=0.04), multiple tumor (P=0.005), and high preoperative creatinine (P=0.036) were independent risk factors for intravesical recurrence. Conclusion: Of the preoperative clinical parameters of UTUC patients, the large tumor, concomitant ipsilateral hydronephrosis, and preoperative anemia were independently associated with cancer-specific mortality after surgery. Ureteral tumor, multiple tumor, and high preoperative creatinine were independently associated with intravesical recurrence after surgery.

Key words: Urothelium, Carcinoma, transitional cell, Neoplasm recurrence, local, Prognosis, Risk factors

中图分类号: 

  • R737.1
[1] 李志存, 吴天俣, 梁磊, 范宇, 孟一森, 张骞. 穿刺活检单针阳性前列腺癌术后病理升级的危险因素分析及列线图模型构建[J]. 北京大学学报(医学版), 2024, 56(5): 896-901.
[2] 黄教悌,胡菁,韩博. 治疗相关神经内分泌前列腺癌机制研究与靶向治疗新进展[J]. 北京大学学报(医学版), 2024, 56(4): 557-561.
[3] 张树栋,谢睿扬. 机器人手术时代的肾癌合并腔静脉瘤栓治疗策略[J]. 北京大学学报(医学版), 2024, 56(4): 562-564.
[4] 邢念增,王明帅,杨飞亚,尹路,韩苏军. 前列腺免活检创新理念的临床实践及其应用前景[J]. 北京大学学报(医学版), 2024, 56(4): 565-566.
[5] 欧俊永,倪坤明,马潞林,王国良,颜野,杨斌,李庚午,宋昊东,陆敏,叶剑飞,张树栋. 肌层浸润性膀胱癌合并中高危前列腺癌患者的预后因素[J]. 北京大学学报(医学版), 2024, 56(4): 582-588.
[6] 颜野,李小龙,夏海缀,朱学华,张羽婷,张帆,刘可,刘承,马潞林. 前列腺癌根治术后远期膀胱过度活动症的危险因素[J]. 北京大学学报(医学版), 2024, 56(4): 589-593.
[7] 于书慧,韩佳凝,钟丽君,陈聪语,肖云翔,黄燕波,杨洋,车新艳. 术前盆底肌电生理参数对前列腺癌根治性切除术后早期尿失禁的预测价值[J]. 北京大学学报(医学版), 2024, 56(4): 594-599.
[8] 刘帅,刘磊,刘茁,张帆,马潞林,田晓军,侯小飞,王国良,赵磊,张树栋. 伴静脉癌栓的肾上腺皮质癌的临床治疗及预后[J]. 北京大学学报(医学版), 2024, 56(4): 624-630.
[9] 虞乐,邓绍晖,张帆,颜野,叶剑飞,张树栋. 具有低度恶性潜能的多房囊性肾肿瘤的临床病理特征及预后[J]. 北京大学学报(医学版), 2024, 56(4): 661-666.
[10] 舒帆,郝一昌,张展奕,邓绍晖,张洪宪,刘磊,王国良,田晓军,赵磊,马潞林,张树栋. 肾部分切除术治疗囊性肾癌的功能学和肿瘤学结果:单中心回顾性研究[J]. 北京大学学报(医学版), 2024, 56(4): 667-672.
[11] 周泽臻,邓绍晖,颜野,张帆,郝一昌,葛力源,张洪宪,王国良,张树栋. 非转移性T3a肾细胞癌患者3年肿瘤特异性生存期预测[J]. 北京大学学报(医学版), 2024, 56(4): 673-679.
[12] 陈延,李况蒙,洪锴,张树栋,程建星,郑仲杰,唐文豪,赵连明,张海涛,姜辉,林浩成. 阴茎海绵体注射试验对阴茎血管功能影响的回顾性研究[J]. 北京大学学报(医学版), 2024, 56(4): 680-686.
[13] 庞博,郭桐君,陈曦,郭华棋,石嘉章,陈娟,王欣梅,李耀妍,单安琪,余恒意,黄婧,汤乃军,王艳,郭新彪,李国星,吴少伟. 天津与上海35岁以上人群氮氧化物个体暴露水平及其影响因素[J]. 北京大学学报(医学版), 2024, 56(4): 700-707.
[14] 和静,房中则,杨颖,刘静,马文瑶,霍勇,高炜,武阳丰,谢高强. 血浆中脂质代谢分子与颈动脉粥样硬化斑块、传统心血管危险因素及膳食因素的关系[J]. 北京大学学报(医学版), 2024, 56(4): 722-728.
[15] 方杨毅,李强,黄志高,陆敏,洪锴,张树栋. 睾丸鞘膜高分化乳头状间皮肿瘤1例[J]. 北京大学学报(医学版), 2024, 56(4): 741-744.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!